OEM News

Abbott Integrates Libre CGM’s Data with Epic’s EHR System

Data from a LibreView account can be automatically linked to Epic so clinicians can view glucose data within Epic.

Author Image

By: Sam Brusco

Associate Editor

Abbott has entered a first-of-its-kind agreement to integrate data from its FreeStyle Libre continuous glucose monitoring (CGM) systems into Epic’s electronic health record (EHR) systems in the U.S.

This partnership aims to boost workflow efficiency through Epic’s Aura software, which brings health systems together with diagnostics labs and medical device manufacturers.

Data from a LibreView account can be automatically linked to Epic so clinicians can view glucose data within Epic before, during, and after meeting with patients. The process allows healthcare providers to access critical glucose data within their preferred workflows to enable more informed care.

Over 575,000 U.S. healthcare providers service 280 million patients will receive access to key glucose data in charts, helping them to spend less time finding data and more on care management. Using Libre systems and Epic lets patients more easily collaborate with providers and use advanced CGM tech to improve engagement and drive behavior change.

“Our goal is to simplify care and drive better outcomes for both providers and patients,” said Lisa Earnhardt, executive VP and group president of medical devices for Abbott. “While the integration with Libre data is Abbott’s first medical device offering with Epic, it’s just the beginning. We aim to expand this model to our other medical devices and connected care platforms in the future.”

“Our work with Abbott aims to make life simpler for the nearly 40 million people in the U.S. who live with diabetes today,” added Alan Hutchison, vice president at Epic. “Diabetes requires close collaboration between patients, primary care providers, and specialists to manage a complex and time-critical care plan. This will help everyone focus more on patient care and less on administrative hurdles.”

Last week, Medtronic has submitted 510(k) applications to the U.S. Food and Drug Administration (FDA) seeking clearance for an interoperable insulin pump. The FDA nod will facilitate system integration with a CGM sensor based on Abbott’s most advanced CGM platform.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters